Personalized Cardiac Therapy using AI-Driven Heart Position State Analysis

Publication ID: 24-11857798_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Personalized Cardiac Therapy using AI-Driven Heart Position State Analysis,” Published Technical Disclosure No. 24-11857798_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857798_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,798.

Summary of the Inventive Concept

The inventive concept discloses a next-generation cardiac sensing and therapy system that leverages AI-driven heart position state analysis to deliver personalized therapy to patients, revolutionizing the field of cardiac care.

Background and Problem Solved

The original patent addresses cardiac sensing and therapy delivery by medical device systems. However, it is limited to using fixed parameters and lacks real-time adaptability to changing patient heart position states. The new inventive concept solves this problem by integrating wearable sensor data, machine learning algorithms, and implantable micro-devices to provide dynamic and personalized cardiac therapy.

Detailed Description of the Inventive Concept

The system comprises a wearable device that tracks patient heart position states using non-invasive electroencephalography sensors and machine learning-based algorithms. The data is transmitted to a cloud-based platform, where it is analyzed using machine learning algorithms to identify trends and patterns. The platform provides personalized cardiac therapy recommendations to clinicians, who can adjust therapy parameters in real-time using a neural network trained to predict patient heart position states. The system can be further enhanced by incorporating a swarm of implantable micro-devices, each configured to sense cardiac electrical signals and deliver cardiac therapy in response to real-time heart position state data.

Novelty and Inventive Step

The new claims introduce the use of AI-driven heart position state analysis, wearable sensor data, and machine learning algorithms to deliver personalized cardiac therapy, which is a significant departure from the fixed parameters and limited adaptability of the original patent. The inventive concept's novelty lies in its ability to adapt to changing patient heart position states over time, providing a more effective and efficient cardiac care solution.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of wearable sensors, such as ECG or accelerometer sensors, or incorporating additional data sources, such as patient activity levels or sleep patterns. Variations could also include different machine learning algorithms or neural network architectures to improve the accuracy of heart position state predictions.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the cardiac care industry, particularly in the areas of personalized medicine and remote patient monitoring. The system could be marketed to hospitals, clinics, and medical device manufacturers, with potential applications in cardiac rehabilitation, arrhythmia management, and cardiovascular disease prevention.

Field of Art

Medical Device Systems, Cardiac Sensing and Therapy Technologies, Biomedical Engineering with specialization in Implantable Medical Devices and Advanced Signal Processing

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, expertise in medical device design, signal processing algorithms, neural network applications in medical technologies, and understanding of cardiac monitoring systems

Obviousness Rationale

A PHOSITA would recognize that the PTD's AI-driven heart position state analysis represents a predictable technological evolution of the source patent's cardiac sensing methodology. The core technical problem of adaptive cardiac therapy parameter modification remains consistent, with machine learning providing a more sophisticated mechanism for achieving the same fundamental goal of personalized cardiac intervention. The integration of wearable sensors and neural networks represents an incremental technological advancement that would be obvious to a skilled practitioner familiar with emerging medical device technologies.

Obvious Combinations & Variations

Source Patent Element
Method for controlling delivery of anti-tachyarrhythmia shock therapy using multiple electrodes and heart position state parameters
PTD Variation
Neural network trained to predict patient heart position states from wearable sensor data with adaptive parameter modification
Obviousness Reasoning
Predictable application of machine learning to existing cardiac sensing methodology, representing a known technique for improving medical device responsiveness
Source Patent Element
Cardiac therapy delivery based on patient posture and respiratory parameters
PTD Variation
Cloud-based platform analyzing heart position state data using machine learning algorithms to identify patient-specific trends
Obviousness Reasoning
Logical extension of existing parametric analysis using advanced computational techniques, representing a design choice within ordinary skill in the art
Source Patent Element
Implantable medical device with multiple electrodes for cardiac sensing
PTD Variation
Swarm of implantable micro-devices configured to sense cardiac signals and deliver therapy based on real-time position state data
Obviousness Reasoning
Incremental technological improvement using known distributed sensing techniques, representing a finite solution to enhanced cardiac monitoring
Source Patent Element
Cardiac therapy parameter modification based on patient physiological state
PTD Variation
Real-time adjustment of cardiac therapy parameters using machine learning algorithms and wearable sensor inputs
Obviousness Reasoning
Application of known machine learning techniques to existing medical device parameter modification, representing a predictable technological progression
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857798 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations obvious, as the disclosed AI-driven cardiac sensing and therapy system represents a predictable technological evolution of existing medical device methodologies, utilizing known machine learning techniques to achieve enhanced personalization of cardiac intervention strategies.

Original Patent Information

Patent NumberUS 11,857,798
TitleModification of cardiac sensing and therapy
Assignee(s)Medtronic, Inc.